DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Eddy SF, Kane SE, Sonenshein GE.
Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate.
Cancer Res 2007;
67: 9018-9023
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.